|
HS Code |
587050 |
| Productname | 4-Iodophenylboronic Acid |
| Casnumber | 1692-15-5 |
| Molecularformula | C6H6BIO2 |
| Molecularweight | 263.83 g/mol |
| Appearance | White to off-white powder |
| Meltingpoint | 221-225 °C |
| Purity | Typically ≥ 97% |
| Solubility | Soluble in DMSO, methanol, ethanol; slightly soluble in water |
| Storagetemperature | 2-8 °C |
| Synonyms | 4-Iodobenzeneboronic acid, Para-iodophenylboronic acid |
| Smiles | B(C1=CC=C(I)C=C1)(O)O |
As an accredited 4-Iodophenylboronic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging for 4-Iodophenylboronic Acid contains 5 grams of white powder, sealed in an amber glass bottle with a screw cap. |
| Shipping | 4-Iodophenylboronic Acid is shipped in tightly sealed containers to prevent moisture exposure. It is packed according to international regulations for hazardous chemicals, typically in ambient temperature conditions. Each package is clearly labeled, with accompanying safety documentation. Handling and transport are managed to ensure product integrity and safe delivery. |
| Storage | 4-Iodophenylboronic acid should be stored in a cool, dry, and well-ventilated area, away from moisture, heat, and sources of ignition. Keep the container tightly closed and protect it from direct sunlight. Store it separately from incompatible substances such as strong oxidizing agents. Proper labeling and secondary containment are recommended to prevent contamination and ensure safe handling. |
Applications of 4-Iodophenylboronic Acid in Industrial Manufacturing4-Iodophenylboronic acid serves as a valuable intermediate in advanced organic synthesis. Its role extends across several specialized industrial value chains, contributing to the manufacture of complex molecules and innovative end-use products through controlled Suzuki coupling reactions and other boronate chemistry. Below, we present main application scenarios from our downstream partners, with detailed compliance, formulation, process, and product insights based on our manufacturing experience. 1. Pharmaceutical Intermediate for Bruton’s Tyrosine Kinase (BTK) InhibitorsMajor pharmaceutical manufacturers utilize this raw material during the multi-step synthesis of BTK inhibitor molecules. The ability to form arylated motifs via Suzuki-Miyaura reaction makes it indispensable for creating the biaryl skeleton integral to new oncology and autoimmune therapies. Production lines require stringent control of residual metals and halogen content at each stage. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Active Ingredient SynthesisManufacturers in the crop protection sector introduce 4-iodophenylboronic acid as a regioselective aryl source in advanced fungicide and herbicide discovery pipelines. The material supports the synthesis of heteroaryl-biaryl scaffolds for active molecules, requiring minimized metal and halogen residues to meet regulatory guidelines for field application. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. OLED and Organic Electronics Material ManufacturingSpecialty electronic chemical manufacturers employ this boronic acid derivative in the synthesis of high-performance organic semiconductors. Its high reactivity allows for precise aryl bridging in process development for hole-transport materials and emitter blocks, with thorough in-process cleaning protocols to avoid device contamination. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Advanced Dye and Pigment SynthesisProducers of specialty dyes use 4-iodophenylboronic acid to create extended conjugated systems via Suzuki cross-coupling, improving light absorption and thermal stability in technical dye products. Batch documentation must track heavy metal levels to comply with environmental discharge norms and customer MSDS requirements. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Custom Fine Chemical Synthesis for ResearchContract research organizations and custom synthesis labs deploy 4-iodophenylboronic acid in the rapid assembly of new aryl-based molecules for screening and structure-activity relationship (SAR) studies. Demand centers on high-purity and traceable batch records, especially where materials support IND (Investigational New Drug) filings or patent applications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 4-Iodophenylboronic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Manufacturing 4-Iodophenylboronic Acid is not just about chemical reactions—it’s about patience, vigilance, and a deep understanding of every raw material’s unpredictable quirks. There’s a lot more to this compound than a product catalog description can explain. 4-Iodophenylboronic Acid—a pale, crystalline powder with the molecular formula C6H4BIO2—anchors its value in cross-coupling chemistry. Our teams don’t simply make it; we track it from the first tank of isopropanol all the way through filtration, drying, and rigorous packaging to safeguard its quality.
We’ve stood over the reactors as boronation proceeds, monitored temperature fluctuations during iodination, and learned how small changes ripple through final purity. We’ve learned that not all boronic acids are born equal and that humility in the face of process complexity often delivers a more consistent product than blind confidence in lab-scale results.
Day after day, we deal with batch-to-batch variation, not just by tallying numbers but by fixing valves, rerunning tests, and reworking material if a single parameter’s out-of-line. Our most widely produced grade of 4-Iodophenylboronic Acid meets a minimum purity of 98 percent by HPLC, which reflects the real working environment of pharmaceutical synthesis. What we ship gets characterized not only for appearance and melting point but also for trace metal content and residual solvents, since these can bottleneck downstream yields.
We adjust particle size distribution based on the needs of both automated synthesizers and conventional reactors. Fine, flowable powder sometimes causes issues for high-throughput robotics—so we create grades with larger, free-draining granules when requested. Packaging choices matter: the stability of the compound depends on how we guard against moisture, so we have learned the rhythms of double-bagging, nitrogen-purging, and resealable drums based on how long the product may sit in various warehouses.
Synthetic chemists focus on the finer details—the difference between chasing a 92 percent yield or getting stuck at 85. Small deviations in boronic acid purity impact catalyst loadings, cause side reactions, and can force an entire project off schedule. Our customers call us not just for standard product but for advice on avoiding the organoiodide impurities that sometimes pop up after shipping or prolonged storage.
We’ve found through years of feedback that “good enough” boronic acid is never good enough for medicinal chemistry. Researchers routinely run iterative Suzuki-Miyaura couplings, where subpar performance multiplies across large arrays of analogues. In fragment-based drug design, developers lean hard on the clean, predictable reactivity of aryl boronic acids. The stability of the iodine substituent on 4-Iodophenylboronic Acid means researchers can introduce this group with high fidelity, then leverage its electronic effects for selectivity in subsequent steps.
Many competitors blend or repackage boring white powder with little attention to its downstream utility. We have invested in both material testing and customer dialogues to avoid these pitfalls. Purity isn’t just a certificate—it’s an insurance policy for anyone running tight syntheses.
Consider the upstream: The iodo group’s sensitivity demands dry, oxygen-free operation during synthesis. Incomplete control produces side products like diiodobenzenes or dehalogenated material. We’ve upgraded our process controls more than once after finding out a microleak in a reactor line wasted a half-batch—painful lessons, but they taught us to spot subtle threats long before routine QC does.
Our purification process drives residual by-products below detection limits. We invested in custom filtration gear after learning commercial systems could leave boron-based artefacts or abnormally high inorganic residues on product. Every washed kilogram tells a story—a bit more patience, a tweak in the solvent profile, or a tighter vacuum to coax the last impurity out.
Applications for 4-Iodophenylboronic Acid are much broader than textbook cross-coupling. Medicinal chemistry groups run thousands of parallel aqueous-phase couplings every year. We keep getting feedback that ease of solubility and reproducibility can change the economics of a whole discovery program. Specialty OLED manufacturers rely on its iodinated aromatic ring for fine-tuning electronic structure and photostability. Agrochemical innovators apply this moiety for late-stage diversification of crop-protective agents, extracting more biological value from each synthetic scaffold.
Whereas earlier generations of boronic acids suffered from sensitivity to air and rapid protodeboronation, our modern grades of 4-Iodophenylboronic Acid carry improved shelf lives and lower hydrolytic loss. This owes much to process choices—dry rooms, careful handling, and sensible packaging. The net result: fewer failures at the bench and less material wasted on rework. We see this play out in pharmaceutical kilo labs, where project timelines ride on predictable building blocks, not production-line drama.
There’s a striking difference between iodinated and other aryl boronic acids. The iodine atom on the para position renders 4-Iodophenylboronic Acid far more reactive in palladium-catalyzed reactions than its bromo- or chloro- counterparts. That means milder conditions deliver better results, or tougher coupling partners get tamed. The dense electron cloud of iodine modulates selectivity in heterocycle formation, which isn’t something generic phenylboronic acids handle well at all.
We also make 4-Bromophenylboronic Acid and 4-Chlorophenylboronic Acid—good compounds with their own followings—but the physical properties and downstream performance of the iodide analog make a big difference for advanced organic synthesis. Improved yields, less need for forcing conditions, and fewer chromatographic headaches distinguish 4-Iodophenylboronic Acid. Customers use it for radiolabeling, where smooth isotopic exchange with radioactive iodine is critical; generic boronic acids simply don’t play that game.
The heightened demand for 4-Iodophenylboronic Acid reflects where the pharmaceutical and materials science industries are heading: more complexity, more regulation, tighter margins for error. We have shifted our own manufacturing priorities in response—strengthening in-process controls, upgrading analytical chemistry, trimming drying times to reduce decomposition. None of these adjustments show up in a certificate of analysis, but any experienced chemist will notice the benefit over long campaign runs.
Running boronic acid production at commercial scale brings hard realities to the surface. Batch chemistry can betray even minor procedural slips—a slightly off temperature or a different solvent rinse leaves you with days of remanufacture. Through many cycles of problem-solving, we have introduced robust operator checklists and daily team reviews to catch trouble early.
Our operators—some with twenty years’ experience—bring that extra layer of vigilance computers don’t. A sharp-eyed technician noticed once that the white crystalline powder “looked just a shade off” under certain lights. That led us to identify trace contamination in a new drum line, which could easily have slipped past screens designed for glassware-scale purity. In commercial settings, these extra steps translate directly into reproducible results on our customers’ HPLC traces.
In earlier days, we dealt with uncontrolled moisture issues. Early shipments in standard bottles risked hydrolysis, so we moved to thick-walled, nitrogen-flushed drums with triple seals. Customers in humid regions thanked us for the improved stability. We’ve replaced basic silica gel packs with calibrated desiccant canisters, based on shelf-life data from returned samples, to further enhance the product’s resilience.
Routine feedback loops with process chemists using our product in kilo- and multi-kilo scale-ups help us calibrate specifications to suit real reactors, not idealized academic diagrams. Some clients request further fine-tuning—once, our ability to reduce total metal impurity content led one US contract manufacturer to switch over completely for a new oncology program. The only reason we could achieve that was by internally tracking the origins of all inorganic additives, going back to the very first drum of boric acid.
On the sustainability front, we recognize our share of responsibility. Large-scale manufacture of aryl boronic acids, especially iodinated forms, can generate halogen-containing waste. We invested in a closed-loop recovery system for solvents and a scrubbing unit for iodine vapor, based on monitoring emissions and waste audit data we collected over the past five years.
Customers in Europe and North America increasingly ask about lifecycle data and green chemistry metrics. Early on, we struggled with margins when replacing certain solvents with greener alternatives, but ongoing improvements in distillation and recovery have helped us shrink both solvent waste and the product’s carbon footprint. Adjusting batch scales to minimize off-specification product and working with downstream users on repurposing residue streams pushed us to new levels of resourcefulness.
The story of 4-Iodophenylboronic Acid is evolving alongside industry needs. Our own teams visit customer sites, troubleshoot reactions, and consult on new project startups in-person—not just over email. One university group in Japan needed custom packaging for glovebox use, so we tailored our logistics to keep the product protected through shipping and unpacking.
We organize technical webinars on coupling chemistry, focusing on best practices with sensitive boronic acids. These exchanges reveal the diversity of synthetic approaches around the world—some researchers work at micromole scale under strictly anhydrous conditions, while others push kilogram-scale reactions in water. Each context points us toward new process optimizations. Last year, we redesigned our drying ovens after a client’s suggestion, resulting in reduced batch cycle times and better shelf stability.
Staying in tune with the evolution of analytical standards matters to us. The growing precision of LC-MS, GC, and NMR techniques puts new pressure on product consistency and purity. We actively benchmark our 4-Iodophenylboronic Acid against international reference standards, always trying to beat our last performance. Failures become the basis for improvement—one failed moisture analysis led to design upgrades in our packaging plant’s humidity control. We document these experiences, building internal know-how that translates into higher-performing product for the next generation of synthesis.
Through thousands of kilograms shipped and hundreds of customer projects, our core belief remains that 4-Iodophenylboronic Acid is as much about reliability as chemical reactivity. Factory procedures, operator experience, environmental controls, and supply chain diligence all factor into the final results on a chemist’s bench. Seamless project execution, fewer impurities, and transparent communications set a manufacturer apart from a trader or a reseller.
For researchers and scale-up chemists depending on every reaction outcome, our direct manufacturing experience makes the difference between project momentum and unforeseen troubleshooting. Each refinement in process, each hour spent on the production floor, and each learning moment from customer feedback keep us focused on delivering a building block that faces reality head-on. We know the stakes because we live them every day.